Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Coronary Artery Disease V: Surgical Management

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

'It works in practice, but does it work in theory?' An important addition to the body of real-world evidence supporting carotid endarterectomy.

Vascular medicine (London, England)·2026

Same author

Identifying patients at elevated risk of stroke after transcarotid artery revascularization.

Journal of vascular surgery·2026

Same author

Is 5.5 cm Still the Optimal Size Threshold to Treat AAA in Men? A Contemporary Cost-Utility Analysis.

Annals of surgery·2026

Same author

Use of pharmacologic guideline-directed medical therapy for peripheral artery disease by sex among patients undergoing revascularization.

Journal of vascular surgery·2026

Same author

Utilization of the stop-short technique in transcarotid artery revascularization is associated with intraoperative common carotid artery dissection.

Journal of vascular surgery·2026

Same author

Instrumental variable estimation of a hazard ratio for treatment with a waiting time without specifying its dependence on unmeasured confounders: application to a procedural registry.

Lifetime data analysis·2026

Search research articles

相关实验视频

Updated: Jun 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

在珊瑚之后的时间内进行再血管化.

Anne R Dionne¹, Jesse A Columbo^1,2, Clay Block^1,3

¹Geisel School of Medicine at Dartmouth College, Hanover, New Hampshire, USA.

JACC. Case reports

|October 3, 2024

概括

对于动脉狭窄的重血管化不太常见,但可能有利于患有严重疾病和肺等并发症的老年患者. 这一案例突出了高风险表型中的潜在益处,这种表型通常被排除在临床试验之外.

关键词:

这种高血压,高血压.狭窄症是一种狭窄症.支架支架是一种支架.血管疾病是一种血管疾病.

更多相关视频

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

相关实验视频

Last Updated: Jun 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Coral Reef Arks: An In Situ Mesocosm and Toolkit for Assembling Reef Communities

Published on: January 6, 2023

科学领域:

心脏病学心脏病学
腎臟病學 (nephrology) 是一種醫學專業.
血管医学血管医学

背景情况:

随机对照试验 (RCT) 已经减少了在动脉狭窄症 (RAS) 中使用动脉复血管化的情况.
这些RCT主要集中在低风险患者身上,不包括具有严重表型的患者.
高度RAS可以导致严重的并发症,如急性肺和渐进性病.

研究的目的:

评估动脉再血管化的潜在益处,在一个高度RAS的老年患者.
描述一个通常被排除在RAS治疗主要临床试验之外的病例表型.

主要方法:

一个88岁的病人的病例报告,患有复发性急性肺 edem 和渐进性病.
这位患者呈现出高度动脉狭窄症.

主要成果:

患者接受了动脉再血管化.
关于肺和病进展的结果在摘要中没有详细说明,但进行了干预.

结论:

在某些患有高度RAS和严重临床表现的老年患者中,可以考虑脏动脉再血管化.
这一案例强调了针对RAS表型患者的个性化治疗决策的重要性,这些患者在大型RCT中没有代表.